Quest Diagnostics Incorporated
DGX
$234.40
-$1.64-0.70%
NYSE
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 11.56B | 11.28B | 11.04B | 10.85B | 10.52B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 11.56B | 11.28B | 11.04B | 10.85B | 10.52B |
| Cost of Revenue | 7.72B | 7.52B | 7.36B | 7.22B | 7.03B |
| Gross Profit | 3.84B | 3.75B | 3.68B | 3.63B | 3.50B |
| SG&A Expenses | 2.00B | 1.96B | 1.92B | 1.89B | 1.83B |
| Depreciation & Amortization | 151.00M | 152.00M | 154.00M | 154.00M | 147.00M |
| Other Operating Expenses | -1.00M | -3.00M | -1.00M | 1.00M | -1.00M |
| Total Operating Expenses | 9.87B | 9.63B | 9.43B | 9.26B | 9.00B |
| Operating Income | 1.69B | 1.65B | 1.61B | 1.59B | 1.52B |
| Income Before Tax | 1.43B | 1.40B | 1.36B | 1.33B | 1.29B |
| Income Tax Expenses | 320.00M | 329.00M | 314.00M | 301.00M | 289.00M |
| Earnings from Continuing Operations | 1.11K | 1.08K | 1.05K | 1.03K | 1.00K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -51.00M | -51.00M | -54.00M | -57.00M | -54.00M |
| Net Income | 1.06B | 1.02B | 992.00M | 969.00M | 950.00M |
| EBIT | 1.69B | 1.65B | 1.61B | 1.59B | 1.52B |
| EBITDA | 2.27B | 2.23B | 2.18B | 2.15B | 2.06B |
| EPS Basic | 9.53 | 9.17 | 8.86 | 8.63 | 8.47 |
| Normalized Basic EPS | 7.94 | 7.66 | 7.42 | 7.20 | 6.94 |
| EPS Diluted | 9.44 | 9.07 | 8.77 | 8.55 | 8.38 |
| Normalized Diluted EPS | 7.85 | 7.57 | 7.34 | 7.11 | 6.85 |
| Average Basic Shares Outstanding | 444.00M | 445.00M | 446.00M | 446.00M | 446.00M |
| Average Diluted Shares Outstanding | 449.00M | 450.00M | 451.00M | 452.00M | 452.00M |
| Dividend Per Share | 3.32 | 3.26 | 3.20 | 3.15 | 3.10 |
| Payout Ratio | 34.18% | 34.86% | 35.58% | 35.81% | 36.00% |